Please feel free to forward to your colleagues and share the news of our journal | Dear Colleague, We are delighted to announce the publication of Volume 5, Issue 3 of Bladder Cancer (BLC). The full contents are freely available online and can be browsed in full below. This issue hosts an outstanding selection of content, including one review article, two systematic reviews, and two research articles. From the editors of the regular journal sections, there are also new Challenging Case and Paper Alert contributions. | As a member of our research community, we would like to invite you to contribute your own research articles to Bladder Cancer, which offers contributing authors many benefits: • First class Editorial Board
• Rigorous peer review and speedy manuscript processing
• Rapid online publication (pre-press) on acceptance
• Articles are currently published Open Access with no article processing fee Submit your manuscript online via msTracker
View detailed Instructions to Authors
Aims and Scope We look forward to working with you. Best wishes, Editors-in-Chief Seth P. Lerner, MD
Scott Department of Urology
Baylor College of Medicine
Houston, Texas, USA
Email: blc@iospress.com Dan Theodorescu, MD, PhD
Samuel Oschin Comprehensive Cancer Institute
Cedars-Sinai Medical Center
Los Angeles, California, USA
Email: blc@iospress.com | All content is currently freely available to all readers Review Article CIS of the Bladder: Significance and Implications for Therapy
Mirabal, Jorge Rivera | Taylor, John A. | Lerner, Seth P. Systematic Reviews Molecular/ Genetic/ Protein Characterizing of Bladder Cancer Circulating Tumor Cells
Seranio, Nicolas | Malkowicz, S. Bruce | Christodouleas, John | Kao, Gary D. PD-L1/PD-1 Biomarker for Metastatic Urothelial Cancer that Progress Post-platinum Therapy: A Systematic Review and Meta-analysis
Tan, Wei Phin | Tan, Wei Shen | Inman, Brant A. Research Articles Investigating the STING Pathway to Explain Mechanisms of BCG Failures in Non-Muscle Invasive Bladder Cancer: Prognostic and Therapeutic Implications
Koti, Madhuri | Chenard, Stephen | Nersesian, Sarah | Vidotto, Thiago | Morales, Alvaro | Siemens, D. Robert Impact of Facility Radiation Patient Volume on Overall Survival in Patients with Muscle Invasive Bladder Cancer Undergoing Trimodality Bladder Preservation Therapy
Fischer-Valuck, Benjamin W. | Rudra, Soumon | Gabani, Prashant | Brenneman, Randall | Mueller, Ryan | Chin, Walter | Gay, Hiram A. | Michalski, Jeff M. | Abraham, Christopher | Baumann, Brian C. Other Content Challenging Cases in Urothelial Cancer
Soloway, Mark S. Paper Alert | Automated Urinalysis Machines: Potential Impact on the Diagnosis of Bladder Cancer
Messing, Edward M. | In cased you missed the announcement in September, we are pleased to inform you that Bladder Cancer is now covered in the in the Science Citation Index-Expanded category in the Web of Science, the citation database that generates impact factors. This achievement, which will provide greater discoverability for BLC articles leading to measurable citations, will result in the journal being assigned its first impact factor in 2020. | Listing articles published only in 2018 & 2019 so you can read the most popular recent content Systematic Review: Targeting HER2 in Bladder Cancer (Review Article in Vol.5, Iss.1, 2019)
Koshkin, Vadim S. | O’Donnell, Peter | Yu, Evan Y. | Grivas, Petros Clinical Development of FGFR3 Inhibitors for the Treatment of Urothelial Cancer (Research Article in Vol.5, Iss.2, 2019)
Ibrahim, Tony | Gizzi, Marco | Bahleda, Ratislav | Loriot, Yohann Intravesical Therapy – BCG and Beyond (Meeting Report in Vol.5, Iss.1, 2019)
Grossman, H. Barton | Lamm, Donald | Sjödahl, Gottfrid | O’Donnell, Michael | Hahn, Noah | Kamat, Ashish Molecular Biomarkers of Response to PD-1/ PD-L1 Immune Checkpoint Blockade in Advanced Bladder Cancer (Systematic Review in Vol.5, Iss.2, 2019)
Tu, Megan M. | Ng, Terry L. | De Jong, Florus C. | Zuiverloon, Tahlita C.M. | Fazzari, Francesco G.T. | Theodorescu, Dan Liquid Biopsy-Analysis of Circulating Tumor DNA (ctDNA) in Bladder Cancer (Review Article in Vol.4, Iss.1, 2018)
Todenhöfer, Tilman | Struss, Werner J. | Seiler, Roland | Wyatt, Alexander William | Black, Peter C. A Clinical Trial of the Intradermal TLR2 Agonist CADI-05 for BCG Recurrent and Unresponsive Non-Muscle Invasive Bladder Cancer (Research Article in Vol.5, Iss.2, 2019
O’Donnell, Michael A. | Singh, Sharwan | Sood, Rajeev | Amlani, Jitendra | Krishnamoorthy, H. | Shukla, Ketan | Mohanty, Nayan | Bhatia, Sushil | Chakraborty, Bhaswat | et al. | Upcoming Webinars BCAN offers regular patient insight webinars, bringing nationally recognized bladder cancer experts directly to patients and families to address important topics related to bladder cancer diagnosis, treatment, research and quality of life. There are two upcoming online webinars taking place within the next month: Ileal Conduit Care – Expert Chat (Dec 12); and Bladder Cancer in Women (Dec 17). Visit the BCAN website for more information and details about how to register for these webinars, and to access the full catalog of past webinars (videos and transcripts are available): | Bladder Cancer has been traveling the world in recent months, with information about the journal available to delegates at conferences where members of the Editorial Board spread word of the excellent research published in the pages of our journal. The journal was promoted to audiences at the following events: BCAN Think Tank (Aug; Washington DC, USA); IBCN Annual Meeting (Oct; Aarhus, Denmark); and Global Congress on Bladder Cancer (Oct; Paris, France). Just a reminder that you can follow the discussion and activities at such events and conferences without even leaving home through the journal's Twitter feed. Join the conversation! #BLC_Journal | Help Spread the News of BLC! | If you know of any colleagues or fellow researchers who are not yet signed up to receive the newsletter, we invite you to share this mailing with them. Click on the visual or access the sign-up link here. BLC has an active social media presence. If you are not yet interacting with the journal on social media, why not take the time today to follow us on Twitter? Be part of the discussion! | You are receiving this mailing as you are signed up to receive news from BLC.
You can unsubscibe or alter your preferences at any time by clicking the links below. | |
